We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Nanomedical Applications Global Market Worth $3.8 Billion by 2013

By LabMedica International staff writers
Posted on 03 Oct 2008
According to a new technical market research report, the global medical market for nanotechnology applications generated US$1.7 billion in 2007. This is expected to increase to $1.9 billion in 2008, and $3.8 billion in 2013 for a compound annual growth rate (CAGR) of 14.9%. Furthermore, this market has the potential to reach $9.4 billion in 2018 at a CAGR of 19.9%.

According to BCC Research (Wellesley, MA, USA), a marketing research company, the market is broken down into the categories of nanoparticles, other nanostructured materials, and nanotools/nanodevices. Of these, the nanoparticles segment has the largest share of the market. Valued at $1.6 billion in 2007, this segment should increase at a CAGR of 13.4% to reach $1.8 billion in 2008 and $3.4 billion in 2013. Nanoparticles could potentially see $7.9 billion in revenue in 2018 with a CAGR of 18.6%.

Other nanostructured materials represent the next largest, and fastest growing, segment. Nanostructured materials generated $36.5 million in 2007 and an estimated $45.1 million in 2008. This should increase to $304.7 million in 2013 for a CAGR of 46.5%. This segment has the potential to reach $1.1 billion in 2018 at a CAGR of 29.4%.

Nanotools and nanodevices have the smallest share of the market, worth $30.5 million in 2007. This is expected to grow at a CAGR of 17.8% to reach $34.2 million in 2008 and $77.6 million in 2013. There is a potential for this segment to generate $287.5 million in 2018 at a CAGR of 29.9%.

Pharmaceutical applications currently dominate the market, according to BCC, accounting for nearly 90% of revenue in 2007, and this trend is expected to continue through 2008. This segment is expected to decrease to less than 70% of the market by 2013 and potentially near 50% of the market by 2018. Nanotechnology applications for medical research and medical devices are both expected to significantly gain in market share, potentially reaching 20% each by 2018.

BCC's market analysis delivers market research reports, newsletters, and conferences that provide companies with the insights needed to make intelligent and strategic business decisions.

Related Links:
BCC Research



New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Rubella Infection ELISA
ReQuest RUBELLA IgM ELISA Kit
New
UHF RFID Tag and Inlay
AD-321r6/AD-321r6-P

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries